The use of mouse models in melanoma with brain metastases to test new therapies
ASCO 2016 melanoma highlights: immunotherapy developments and further data on checkpoint inhibitors
Immunotherapy: effective yet complex drugs
Updated outcomes of KEYNOTE-010 of pembrolizumab for NSCLC
What is the future for patients with metastatic sarcoma?
Breelyn A. Wilky